Illicit only (n = 687) | Prescribed only (n = 124) | Dual (n = 252) | Total (n = 1063) | |||||
---|---|---|---|---|---|---|---|---|
n | % | n | % | n | % | n | % | |
Age (mean, SD) | 47.2 (13.9) | 48.6 (13.2) | 42.8 (11.7) | 46.3 (13.5) | ||||
Gender | ||||||||
Female | 302 | 44.0 | 72 | 58.1 | 86 | 34.1 | 460 | 43.3 |
Male | 379 | 55.2 | 52 | 41.9 | 163 | 64.7 | 594 | 55.9 |
Other | 6 | 0.01 | 0 | 0.0 | 3 | 1.2 | 9 | 0.01 |
Route of administration | ||||||||
Inhaled | 416 | 61.6 | 14 | 11.5 | 94 | 37.9 | 524 | 50.1 |
Oral | 259 | 38.4 | 108 | 88.5 | 61 | 24.6 | 428 | 41.0 |
Oral + inhaled | 0 | 0 | 0 | 0 | 93 | 37.5 | 93 | 8.9 |
Cannabinoid | ||||||||
THC dominant | 200 | 29.4 | 19 | 15.3 | 120 | 57.2 | 339 | 33.5 |
Balanced | 122 | 18.0 | 47 | 37.9 | 0 | 0 | 169 | 16.7 |
CBD dominant | 147 | 21.6 | 57 | 45.9 | 18 | 8.6 | 222 | 21.9 |
Unknown | 210 | 30.9 | 1 | 0.8 | 72 | 34.3 | 283 | 27.9 |
Education | ||||||||
Primary | 5 | 0.7 | 1 | 0.9 | 2 | 0.8 | 8 | 0.8 |
High school | 133 | 19.5 | 20 | 18.3 | 34 | 13.7 | 187 | 17.6 |
Trade | 259 | 38.0 | 38 | 34.9 | 107 | 43.1 | 429 | 40.4 |
Undergrad | 193 | 28.3 | 28 | 25.7 | 68 | 27.4 | 150 | 14.1 |
Postgrad | 91 | 13.4 | 22 | 20.2 | 37 | 14.9 | 289 | 27.2 |
Employment | ||||||||
FT/PT | 361 | 52.5 | 57 | 46.0 | 140 | 55.6 | 558 | 43.6 |
Unemployed | 59 | 8.6 | 12 | 9.7 | 28 | 11.1 | 99 | 7.7 |
Home/student | 68 | 9.9 | 12 | 9.7 | 16 | 6.4 | 96 | 7.5 |
Retired | 85 | 12.4 | 19 | 15.3 | 18 | 7.1 | 122 | 9.5 |
Disability | 114 | 16.6 | 24 | 19.4 | 50 | 19.8 | 406 | 31.7 |
General condition | ||||||||
Cancer | 70 | 4.4 | 6 | 2.4 | 14 | 2.6 | 10 | 1.8 |
Gastrointestinal | 133 | 8.3 | 17 | 6.9 | 30 | 5.6 | 29 | 5.2 |
Mental health | 347 | 21.7 | 39 | 15.9 | 121 | 22.7 | 136 | 24.6 |
Neurological | 103 | 6.4 | 20 | 8.1 | 30 | 5.6 | 43 | 7.8 |
Pain | 508 | 31.7 | 95 | 38.6 | 178 | 33.3 | 181 | 32.7 |
Sleep | 440 | 27.5 | 69 | 28.0 | 161 | 30.1 | 154 | 27.8 |